Monique V. Davies

University of Auckland — New Zealand

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index6.5kcitations42works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA and protein synthesis mechanisms(12), Muscle Physiology and Disorders(11), RNA regulation and disease(8), Virus-based gene therapy research(7), Viral Infections and Immunology Research(6)

Publications42 total

Increasing early childhood education enrolment and attendance rates in south Auckland, New Zealand
Figshare·2025· 1 citedOpen Access
Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease
Scientific Reports·2019· 49 citedOpen Access
Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
Journal of Pharmacology and Experimental Therapeutics·2018· 26 citedOpen Access
ACE-083, a locally-acting TGF-β; superfamily ligand trap, increases muscle mass and strength in a mouse model of Duchenne muscular dystrophy
Neuromuscular Disorders·2016· 3 cited
ACE-083 increases muscle hypertrophy and strength in C57BL/6 mice
Neuromuscular Disorders·2015· 6 cited
ACE-2494, a novel GDF ligand trap, increases muscle and bone mass upon systemic administration in mice
Neuromuscular Disorders·2015· 1 cited
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
Nature Medicine·2014· 421 cited
ACE-536, a Modified Type II Activin Receptor Increases Red Blood Cells In Vivo by Promoting Maturation of Late Stage Erythroblasts
Blood·2010· 3 cited
A Soluble Activin Receptor Type IIB Prevents the Effects of Androgen Deprivation on Body Composition and Bone Health
Endocrinology·2010· 72 citedOpen Access
Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB
Journal of Biological Chemistry·2010· 149 citedOpen Access
A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys
Bone·2010· 126 cited
Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis)
Bone·2009· 64 cited
Posttranslational Modifications Limit High Level Expression of Functionally Active Chimeric P-Selectin Glycoprotein Ligand-1 in rCHO Cells
2008
Mo-P1:113 Inhibition of apolipoprotein A-I glycation restores its ability to activate lecithin: Cholesterol acyl transferase
Atherosclerosis Supplements·2006
Mo-P1:114 Evidence that glycation of apolipoprotein A-I inhibits the anti-inflammatory properties of HDL in vivo
Atherosclerosis Supplements·2006
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
Proceedings of the National Academy of Sciences·2005· 493 citedOpen Access
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases
Proceedings of the National Academy of Sciences·2003· 445 citedOpen Access
The double-stranded RNA-activated protein kinase mediates viral-induced encephalitis
Virology·2003· 22 cited
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
Biochemical and Biophysical Research Communications·2003· 491 cited
The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum
Journal of Biological Chemistry·2002· 438 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Randal J. Kaufman(19), R. Scott Pearsall(10), Dianne Sako(9), Asya V. Grinberg(8), Kathryn Underwood(6), Jasbir Seehra(6), Ravindra Kumar(6), Roselyne Castonguay(6), Neil M. Wolfman(5), Kathleen Tomkinson(5), John W.B. Hershey(5), Katia Liharska(5), M. Cannell(5), M. Troy(5), Travis Monnell(4), Jeffrey A. Ucran(4), Se‐Jin Lee(3), Jill F. Wright(3), Rajasekhar N.V.S. Suragani(3), L C Wasley(3)